Acute Hospital Admissions Because of Health Care-Related Adverse Events: A Retrospective Study of 5 Specialist Departments

Journal of the American Medical Directors Association

Volumn 16, Issue 12, 2015, Pages 1055-1061

  Magdelijns, Fabienne J H ^a   Pijpers, Evelien ^a   Rouhl, Rob P W ^a   Hannemann, Pascal F W ^a   ten Broeke, René H M ^a   Dings, Jim T A ^a   Stehouwer, Coen D A ^a,b   Stassen, Patricia M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Acute admissions; Adverse drug reactions events; Adverse events; The Netherlands

Indexed keywords

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CHILD; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HEALTH CARE; HEALTH CARE RELATED ADVERSE EVENT; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTERNIST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEUROLOGIST; NEUROSURGEON; NEUROSURGERY; ORTHOPEDIC SURGEON; RETROSPECTIVE STUDY; VERY ELDERLY; CLINICAL AUDIT; HOSPITAL DEPARTMENT; INFANT; MEDICAL ERROR; MIDDLE AGED; NETHERLANDS; PRESCHOOL CHILD; SPECIALIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITAL DEPARTMENTS; HOSPITALIZATION; HUMANS; INFANT; MALE; MEDICAL AUDIT; MEDICAL ERRORS; MIDDLE AGED; NETHERLANDS; RETROSPECTIVE STUDIES; SPECIALIZATION; YOUNG ADULT;

EID: 84947867641     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2015.06.019     Document Type: Article

References (36)

1. de Vries E.N., Ramrattan M.A., Smorenburg S.M., et al. The incidence and nature of in-hospital adverse events: A systematic review. Qual Saf Health Care 2008, 17:216-223.
2. Leendertse A.J., Egberts A.C., Stoker L.J., van den Bemt P.M. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008, 168:1890-1896.
3. Alvarez P.A., Bril F., Castro V., et al. Adverse drug reactions as a reason for admission to an internal medicine ward in Argentina. Int J Risk Saf Med 2013, 25:185-192.
4. Pirmohamed M., James S., Meakin S., et al. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients. BMJ 2004, 329:15-19.
5. Leendertse A.J., Van Den Bemt P.M., Poolman J.B., et al. Preventable hospital admissions related to medication (HARM): Cost analysis of the HARM study. Value Health 2011, 14:34-40.
6. Magdelijns F.J., Gulikers D., Pijpers E., et al. Registering complications at admission via the emergency department: An opportunity for improvement. Neth J Med 2013, 71:44-49.
7. Thijssen W.A., Giesen P.H., Wensing M. Emergency departments in The Netherlands. Emerg Med J 2012, 29:6-9.
8. Nederlandse Vereniging Voor Heelkunde. The Netherlands. Available at: . Accessed January 10, 2014. http://www.heelkunde.nl/kwaliteit/complicatieregistratie.
9. Nederlandse Orthopaedische Vereniging (NOV). The Netherlands. Available at: . Accessed October 1, 2014. http://www.orthopeden.org/kwaliteit/complicatieregistratie.
10. Nederlandse Vereniging voor Neurologie (NVN). The Netherlands. Available at: (only accessible for members). Accessed October 1, 2014. http://www.neurologie.nl/leden/beroepsinformatie/kwaliteitsmeting/complicatieregistratie.
11. Nederlandse Vereniging voor Neurochirurgie (NVvN). The Netherlands. Available at: . Accessed October 1, 2014. http://www.nvvn.org/patienteninfo/alg-over-neurochirurgie-in-het-algemeen.php.
12. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987, 40:373-383.
13. Quan H., Li B., Couris C.M., et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 2011, 173:676-682.
14. Schumock G.T., Thornton J.P. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992, 27:538.
15. Viera A.J., Garrett J.M. Understanding interobserver agreement: The kappa statistic. Fam Med 2005, 37:360-363.
16. Voskuijl T., Hageman M., Ring D. Higher Charlson Comorbidity Index scores are associated with readmission after orthopaedic surgery. Clin Orthop Relat Res 2014, 472:1638-1644.
17. Chen Y.C., Fan J.S., Hsu T.F., et al. Detection of patients presenting with adverse drug events in the emergency department. Intern Med J 2012, 42:651-657.
18. Zhang M., Holman C.D., Price S.D., et al. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: Retrospective cohort study. BMJ 2009, 338:a2752.
19. Allaudeen N., Vidyarthi A., Maselli J., Auerbach A. Redefining readmission risk factors for general medicine patients. J Hosp Med 2011, 6:54-60.
20. Pouyanne P., Haramburu F., Imbs J.L., Begaud B. Admissions to hospital caused by adverse drug reactions: Cross sectional incidence study. French Pharmacovigilance Centres. BMJ 2000, 320:1036.
21. Gawande A.A., Thomas E.J., Zinner M.J., Brennan T.A. The incidence and nature of surgical adverse events in Colorado and Utah in 1992. Surgery 1999, 126:66-75.
22. van der Grinten M., Verhaar J.A. [Dislocation of total hip prostheses; risk factors and treatment]. Ned Tijdschr Geneeskd 2003, 147:286-290. Dutch.
23. Valen B. Dislocation of hip prostheses. Tidsskr Nor Laegeforen 2013, 133:1197-1199.
24. Arvidsson S., Ouchterlony J., Nilsson S., et al. The Gothenburg study of perioperative risk. I. Preoperative findings, postoperative complications. Acta Anaesthesiol Scand 1994, 38:679-690.
25. Unbeck M., Muren O., Lillkrona U. Identification of adverse events at an orthopedics department in Sweden. Acta Orthop 2008, 79:396-403.
26. Schols A.M., Schreuder F.H., van Raak E.P., et al. Incidence of oral anticoagulant-associated intracerebral hemorrhage in the Netherlands. Stroke 2014, 45:268-270.
27. Flaherty M.L. Anticoagulant-associated intracerebral hemorrhage. Semin Neurol 2010, 30:565-572.
28. Rosand J., Eckman M.H., Knudsen K.A., et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 2004, 164:880-884.
29. Tohmo H., Vuorinen E., Muuronen A. Prolonged impairment in activities of daily living due to postdural puncture headache after diagnostic lumbar puncture. Anaesthesia 1998, 53:299-302.
30. Alstadhaug K.B., Odeh F., Baloch F.K., et al. Post-lumbar puncture headache. Tidsskr Nor Laegeforen 2012, 132:818-821.
31. Bezov D., Ashina S., Lipton R. Post-dural puncture headache: Part II-prevention, management, and prognosis. Headache 2010, 50:1482-1498.
32. Tarkkila P.J., Miralles J.A., Palomaki E.A. The subjective complications and efficiency of the epidural blood patch in the treatment of postdural puncture headache. Reg Anesth 1989, 14:247-250.
33. Lee J.K., Seok J.Y., Lee J.H., et al. Incidence and risk factors of ventriculoperitoneal shunt infections in children: A study of 333 consecutive shunts in 6 years. J Korean Med Sci 2012, 27:1563-1568.
34. Conen A., Walti L.N., Merlo A., et al. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: A retrospective analysis over an 11-year period. Clin Infect Dis 2008, 47:73-82.
35. Fischhoff B. Hindsight not equal to foresight: The effect of outcome knowledge on judgment under uncertainty. 1975. Qual Saf Health Care 2003, 12:304-311. discussion 11-12.
36. Michel P., Quenon J.L., de Sarasqueta A.M., Scemama O. Comparison of three methods for estimating rates of adverse events and rates of preventable adverse events in acute care hospitals. BMJ 2004, 328:199.